Jo P - Search Results

1

Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial.

Rau B, Lang H, Koenigsrainer A, Gockel I, Rau HG, Seeliger H, Lerchenmueller C, Reim D, Wahba R, Angele M, Heeg S, Keck T, Weimann A, Topp S, Piso P, Brandl A, Schuele S, Jo P, Pratschke J, Wegel S, Rehders A, Moosmann N, Gaedcke J, Heinemann V, Trips E, Loeffler M, Schlag PM, Thuss-Patience P. Rau B, et al. Among authors: jo p. J Clin Oncol. 2024 Jan 10;42(2):146-156. doi: 10.1200/JCO.22.02867. Epub 2023 Oct 31. J Clin Oncol. 2024. PMID: 37906724 Free PMC article. Clinical Trial.

2

[Incidence and Predictive Factors for Bilaterality in Patients with Papillary Thyroid Carcinoma].

Jo P, Kesruek H, Nietert M, Sahlmann CO, Gaedcke J, Ghadimi M, Sperling J. Jo P, et al. Zentralbl Chir. 2018 Aug;143(4):361-366. doi: 10.1055/a-0651-0878. Epub 2018 Aug 22. Zentralbl Chir. 2018. PMID: 30134494 German.

3

CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer.

Jo P, Jung K, Grade M, Conradi LC, Wolff HA, Kitz J, Becker H, Rüschoff J, Hartmann A, Beissbarth T, Müller-Dornieden A, Ghadimi M, Schneider-Stock R, Gaedcke J. Jo P, et al. Surgery. 2012 Apr;151(4):564-70. doi: 10.1016/j.surg.2011.08.013. Epub 2011 Oct 14. Surgery. 2012. PMID: 22001634

4

A new sensitivity-preferred strategy to build prediction rules for therapy response of cancer patients using gene expression data.

Jung K, Grade M, Gaedcke J, Jo P, Opitz L, Becker H, Ghadimi BM, Beissbarth T. Jung K, et al. Among authors: jo p. Comput Methods Programs Biomed. 2010 Nov;100(2):132-9. doi: 10.1016/j.cmpb.2010.03.016. Epub 2010 Apr 10. Comput Methods Programs Biomed. 2010. PMID: 20382441

5

Acute toxicity of radiochemotherapy in rectal cancer patients: a risk particularly for carriers of the TGFB1 Pro25 variant.

Schirmer MA, Mergler CP, Rave-Fränk M, Herrmann MK, Hennies S, Gaedcke J, Conradi LC, Jo P, Beissbarth T, Hess CF, Becker H, Ghadimi M, Brockmöller J, Christiansen H, Wolff HA. Schirmer MA, et al. Among authors: jo p. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):149-57. doi: 10.1016/j.ijrobp.2011.05.063. Epub 2011 Oct 12. Int J Radiat Oncol Biol Phys. 2012. PMID: 22000747 Clinical Trial.

6

Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g.

Salendo J, Spitzner M, Kramer F, Zhang X, Jo P, Wolff HA, Kitz J, Kaulfuß S, Beißbarth T, Dobbelstein M, Ghadimi M, Grade M, Gaedcke J. Salendo J, et al. Among authors: jo p. Radiother Oncol. 2013 Sep;108(3):451-7. doi: 10.1016/j.radonc.2013.06.032. Epub 2013 Aug 7. Radiother Oncol. 2013. PMID: 23932154

7

Preoperative Prediction of Lymph Node Status by Circulating Mir-18b and Mir-20a During Chemoradiotherapy in Patients with Rectal Cancer.

Azizian A, Kramer F, Jo P, Wolff HA, Beißbarth T, Skarupke R, Bernhardt M, Grade M, Ghadimi BM, Gaedcke J. Azizian A, et al. Among authors: jo p. World J Surg. 2015 Sep;39(9):2329-35. doi: 10.1007/s00268-015-3083-8. World J Surg. 2015. PMID: 25990502

8

Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgery.

Hu Y, Gaedcke J, Emons G, Beissbarth T, Grade M, Jo P, Yeager M, Chanock SJ, Wolff H, Camps J, Ghadimi BM, Ried T. Hu Y, et al. Among authors: jo p. Genes Chromosomes Cancer. 2018 Mar;57(3):140-149. doi: 10.1002/gcc.22512. Epub 2017 Nov 28. Genes Chromosomes Cancer. 2018. PMID: 29119627 Free PMC article.

9

KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy.

Gaedcke J, Grade M, Jung K, Schirmer M, Jo P, Obermeyer C, Wolff HA, Herrmann MK, Beissbarth T, Becker H, Ried T, Ghadimi M. Gaedcke J, et al. Among authors: jo p. Radiother Oncol. 2010 Jan;94(1):76-81. doi: 10.1016/j.radonc.2009.10.001. Epub 2009 Nov 11. Radiother Oncol. 2010. PMID: 19913317 Free PMC article.

10

Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas.

Gaedcke J, Grade M, Jung K, Camps J, Jo P, Emons G, Gehoff A, Sax U, Schirmer M, Becker H, Beissbarth T, Ried T, Ghadimi BM. Gaedcke J, et al. Among authors: jo p. Genes Chromosomes Cancer. 2010 Nov;49(11):1024-34. doi: 10.1002/gcc.20811. Genes Chromosomes Cancer. 2010. PMID: 20725992 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page